Search
Lodiperone
go.drugbank.com/drugs/DB21210ExperimentalLodiperone has a monoisotopic molecular weight of 435.09 Da. … The usage of the INN stem '-perone' in the name indicates that Lodiperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.
Murocainide
go.drugbank.com/drugs/DB21243ExperimentalMurocainide has a monoisotopic molecular weight of 377.2 Da. … The usage of the INN stem '-cain-' in the name indicates that Murocainide is a class I antiarrhythmic, procainamide and lidocaine derivative.
Zocainone
go.drugbank.com/drugs/DB21326ExperimentalThe usage of the INN stem '-cain-' in the name indicates that Zocainone is a class I antiarrhythmic, procainamide and lidocaine derivative. Zocainone has a monoisotopic molecular weight of 353.2 Da.
Atrimustine
go.drugbank.com/drugs/DB21376ExperimentalAtrimustine has a monoisotopic molecular weight of 719.28 Da. … The usage of the INN stem '-mustine' in the name indicates that Atrimustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.
Pirenperone
go.drugbank.com/drugs/DB21405ExperimentalPirenperone has a monoisotopic molecular weight of 393.19 Da. … The usage of the INN stem '-perone' in the name indicates that Pirenperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.
Cinsebrutinib
go.drugbank.com/drugs/DB21640ExperimentalCinsebrutinib has a monoisotopic molecular weight of 383.2 Da. … The usage of the INN stem '-brutinib' in the name indicates that Cinsebrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.
Surzetoclax
go.drugbank.com/drugs/DB21698InvestigationalThe usage of the INN stem '-toclax' in the name indicates that Surzetoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor. Surzetoclax has a monoisotopic molecular weight of 1038.41 Da.
Ciclesonide
go.drugbank.com/drugs/DB01410ApprovedInvestigationalCiclesonide is a glucocorticoid used to treat obstructive airway diseases. It is marketed under the brand name Alvesco.
Butorphanol
go.drugbank.com/drugs/DB00611ApprovedIllicitVet approvedIt is used in the management of severe pain.
Synonyms: (−)-N-cyclobutylmethyl-3,14-dihydroxymorphinanAnacaulase
go.drugbank.com/drugs/DB17449ApprovedInvestigational[A256047,A256052,A256057] The EMA approved the use of anacaulase in 2013,[A256047,A256052] and in January 2023, anacaulase received FDA approval.[L44717] … [L44717] Anacaulase is indicated for eschar removal in patients with deep partial thickness and/or full-thickness thermal burns.